BROOKE KENNEDY: Open Payments
NPI 1487693644 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 70 payments from 18 companies in 2025. Trend: 2023 $739 · 2024 $1,613 · 2025 $1,278
Food & beverage: $1,266Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $444 |
| Vanda Pharmaceuticals Inc. | 9 | $246 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Dexcom, Inc. | 4 | $71 |
| Novo Nordisk Inc | 4 | $66 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 3 | $48 |
| Boston Scientific Corporation | 1 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: VRAYLAR, FANAPT, UBRELVY, QULIPTA, Dexcom G6 Transmitter, JARDIANCE, Auvelity, Ozempic.
Industry payments across LA — which companies pay providers there.
